Gilead

A drug developed by Gilead Sciences is showing promise in the fight against COVID-19, with a government study indicating remdesivir has a “clear-cut” effect in cutting the time patients need to recover. “What it has proven is that a drug can block this virus,” said Anthony Fauci, who directs infectious diseases research at the National…

Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of antiviral drug remdesivir improved and more than half were discharged from the hospital within two weeks.The company also said another trial by the National Institute of Allergy and Infectious Diseases met its…

Need help? Contact us We've detected unusual activity from your computer network To continue, please click the box below to let us know you're not a robot. Why did this happen? Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review…

Gilead Sciences (GILD) has accused the U.S. government of breaching several contracts and “secretly” obtaining patents stemming from research that led to the ground-breaking Truvada HIV-prevention pill. In a lawsuit filed late Friday, the drug maker claimed the Centers for Disease Control and Prevention violated the terms of a 15-year-old collaboration by failing to notify…

Get all the latest news on coronavirus and more delivered daily to your inbox.  Sign up here.Gilead Sciences is responding to a World Health Organization report that its experimental antiviral drug failed to help patients with severe COVID-19 in a clinical trial conducted in China.Gilead said the findings were inconclusive because the study was terminated early..GET FOX BUSINESS…